Psyber

Psyber is a health care startup under the umbrella of atai Life Sciences, with a mission to revolutionize mental health treatment through technology and medicine. Their groundbreaking focus lies in the development of brain-computer interface-enabled (BCI) digital therapeutics, with the strategic incorporation of psychedelics. This approach enables them to empower patients by providing improved access to psychotherapy, transcending the constraints of time and location.

Based in the United States, Psyber's ambition to leverage the potential of BCI-enabled digital therapeutics has captured the attention of the venture capital sphere. With a strong emphasis on the global reach of their innovative solutions, Psyber represents a compelling opportunity for investors seeking to support pioneering advancements in mental health care.